HWH-340

N/A

Report date: 2025/01/21 14:00:32
NME

Base Information

Drug NameHWH-340
Drug Alias NameHWH-340WXFL10040340WXFL-10040340
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitors
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWuhan Kemei Lide Biomedicine Co LtdHumanwell Healthcare (Group) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHubei Bio-Pharmaceutical Industrial Technological Institute IncHumanwell Healthcare (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A